Blueprint Genetics

Uses Next Generation Sequencing (NGS) to perform diagnostics on genetic diseases.

Launch date

Apr 2012

Employees

Market cap

Enterprise valuation

Company register number 2230790-0

Espoo Uusimaa (HQ)

http://www.blueprintgenetics.com/

https://twitter.com/bpgenetics https://www.facebook.com/blueprintgenetics https://www.linkedin.com/company/blueprint-genetics/

View job openings

Revenues, earnings & profits over time

EUR	2017	2018	2019	2020	2021	2022	2023
Revenues	8.1m	10.3m	15.4m	16.1m	22.9m	22.8m	22.8m
% growth	248 %	27 %	50 %	5 %	42 %	(1 %)	-
EBITDA	(3.0m)	(6.5m)	(4.0m)	(5.5m)	3.3m	(4.5m)	-
% EBITDA margin	(37 %)	(64 %)	(26 %)	(34 %)	15 %	(20 %)	-
Profit	(4.7m)	(9.2m)	(7.0m)	(8.3m)	1.5m	(6.0m)	-
% profit margin	(59 %)	(90 %)	(45 %)	(51 %)	6 %	(26 %)	-
R&D budget	8.0m	10.0m	20.0m	20.0m	-	-	-
R&D % of revenue	99 %	98 %	130 %	124 %	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
-	Cota Capital MBC Biolabs Bootstrap Europe	N/A	-
Jan 2014	Wallstreet Financial Services	€2.4m	Early VC
Aug 2014	InVenture Partners	$3.9m	Seed
Sep 2014	InVenture Partners Inventure Pontos Group	€3.5m	Early VC
Dec 2016	Inventure Pontos Group	€6.0m	Early VC
Jan 2017	InVenture Partners Pontos Group Avohoidon Tutkimussäätiö Sr Botnia Scan	€3.5m Valuation: €30.0m 12.9x EV/LTM Revenues -12.6x EV/LTM EBITDA	Early VC
Jul 2017*	Creathor Ventures InVenture Partners MTIP Pontos Group	€14.0m	Series A
Nov 2019	N/A	N/A	Series B
Sep 2020*	N/A	N/A	Debt
Total Funding		€32.9m

Tech stackLearn more about the technologies and tools that this company uses.